Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Thoracic 3Gastrointestinal 3Head & Neck 2Genitourinary 2Breast 2Sarcoma 1Other solid neoplasm 1Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1

Interventions

gallium Ga 68 dotatate 690Y-octreotide, DOTA-Tyr(3)- 3Single Photon Emission Computed Tomography Computed Tomography 2Magnetic Resonance Spectroscopy 23-Iodobenzylguanidine 2trametinib 1sacubitril and valsartan sodium hydrate drug combination 1lutetium Lu 177 dotatate 1lanreotide 1corticorelin ovine 1Tomography, X-Ray Computed 1Tomography, Emission-Computed, Single-Photon 1Sitagliptin Phosphate 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Microscopy, Electron 1Metformin 1Liraglutide 1Iodine-123 1Ga(III)-DOTATOC 1CYT-6091 168Ga-pentixafor 168Ga-NOTA-exendin-4 168Ga-FAPI 164Cu-SARTATE 16-fluorodopamine 13-fluorobenzylguanidine 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Paclitaxel × Endocrine × Clear all
NCT03085056 2025-07-03

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
13 enrolled
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡